Improving sleep for parents and infants through a sleep intervention

Efficacy of Parent-child Sleep Intervention to Improve Sleep Quality, Psychological Health, and Infant Health in Parents of Neonates.

Not applicable Interventional Taipei Veterans General Hospital, Taiwan · NCT06143917

This study is testing a new sleep program for parents and their newborns in a special care nursery to see if it can help them sleep better and improve their overall well-being.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment360 (estimated)
Ages18 Years to 60 Years
SexAll
SponsorTaipei Veterans General Hospital, Taiwan Government
Locations1 site (Taipei)
Trial IDNCT06143917 on ClinicalTrials.gov

What this trial studies

This clinical trial aims to develop and evaluate a parent-child sleep intervention designed to enhance sleep quality, psychological health, and overall infant health among parents of neonates in an intermediate care nursery. The study will involve 102 pairs of parents and infants, who will be randomly assigned to either an experimental group receiving the intervention or a control group. Various measures, including sleep quality indices and psychological assessments, will be utilized to gauge the effectiveness of the intervention, with data analyzed through statistical methods to determine outcomes.

Who should consider this trial

Good fit: Ideal candidates for this study are postpartum women aged 18 or older with a singleton pregnancy and infants at least 32 weeks gestational age who experience significant sleep disturbances.

Not a fit: Patients diagnosed with insomnia disorders, anxiety disorders, or depression, as well as those with certain medical conditions or working in shifts, may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly improve sleep quality and mental well-being for parents, leading to better health outcomes for both parents and their infants.

How similar studies have performed: Other studies have shown promising results with similar parent-child sleep interventions, indicating potential for success in this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Postpartum women aged 18 years or older.
* Postpartum women with a singleton pregnancy, and the gestational age of their infant is at least 32 weeks.
* Postpartum women with a severe insomnia severity index score of ≥8 points.
* Postpartum women and their husbands or partners capable of reading, understanding, and communicating in Mandarin.
* Postpartum women and their husbands or partners with internet access and the ability to operate resources using a smartphone, tablet, or computer.
* Both postpartum women and their husbands or partners are willing to participate in the research process.

Exclusion Criteria:

* Postpartum women diagnosed with Insomnia Disorder, Anxiety Disorders, or Depression.
* Postpartum women suffering from arrhythmia or cardiovascular diseases.
* Postpartum women working in shifts.
* Infants with congenital abnormalities, neurological impairments (such as hydrocephalus, periventricular leukomalacia), requiring the use of tubes or respirators after discharge, or using medications that might affect sleep (such as caffeine, sedatives, muscle relaxant, anti-epileptic drugs, or pain medications).

Where this trial is running

Taipei

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Sleep QualityPsychological HealthInfant HealthParentsNeonateSleep educationSleep qualityPsychological health
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.